News

Ajinomoto Bio-Pharma, CytoDyn sign manufacturing partnership for COVID-19 drug in clinical trials

CytoDyn is currently enrolling patients in two placebo-controlled randomized clinical trials for Phase 2 and Phase 2b/3.

Read More

May 06, 2020

By : Team ABLE

CEPI launches a new Call for Proposals to accelerate COVID-19 vaccine development and production

Focus for funding will be on vaccine candidates that have the potential to be developed rapidly and manufactured globally at scale

Read More

May 06, 2020

By : Team ABLE

Pfizer, BioNTech dose first participants in USA as part of global COVID-19 MRNA vaccine development program

First participants were dosed at NYU Grossman School of Medicine and University of Maryland School of Medicine

Read More

May 06, 2020

By : Team ABLE

India’s first COVID 19 test bus launched in Mumbai

The Bus is an initiative by the C19 Taskforce of IIT Alumni Council that was brought to life with support from the Health Department.

Read More

May 06, 2020

By : Team ABLE

Glenmark receives DCGI approval to conduct trials in India on Favipiravir antiviral tablets for COVID-19 patients

The product is a generic version of Avigan of Fujifilm Toyama. Favipiravir has demonstrated activity against influenza viruses and has been approved in Japan for the treatment of novel influenza virus infections.

Read More

May 05, 2020

By : Team ABLE

 

voice for BT and BEST 2026

Applications Open now

Apply for the Indo-Boston Biotech Bridge Award

Calling All Indian Biotech Startups

Focus Areas

Highlights